Article thumbnail

Cell-type-specific long-range looping interactions identify distant regulatory elements of the CFTR gene

By Nele Gheldof, Emily M. Smith, Tomoko M. Tabuchi, Christoph M. Koch, Ian Dunham, John A. Stamatoyannopoulos and Job Dekker


Identification of regulatory elements and their target genes is complicated by the fact that regulatory elements can act over large genomic distances. Identification of long-range acting elements is particularly important in the case of disease genes as mutations in these elements can result in human disease. It is becoming increasingly clear that long-range control of gene expression is facilitated by chromatin looping interactions. These interactions can be detected by chromosome conformation capture (3C). Here, we employed 3C as a discovery tool for identification of long-range regulatory elements that control the cystic fibrosis transmembrane conductance regulator gene, CFTR. We identified four elements in a 460-kb region around the locus that loop specifically to the CFTR promoter exclusively in CFTR expressing cells. The elements are located 20 and 80 kb upstream; and 109 and 203 kb downstream of the CFTR promoter. These elements contain DNase I hypersensitive sites and histone modification patterns characteristic of enhancers. The elements also interact with each other and the latter two activate the CFTR promoter synergistically in reporter assays. Our results reveal novel long-range acting elements that control expression of CFTR and suggest that 3C-based approaches can be used for discovery of novel regulatory elements

Topics: Gene Regulation, Chromatin and Epigenetics
Publisher: Oxford University Press
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2004). 3C technology: analyzing the spatial organization of genomic loci in vivo.
  2. (2009). A complex intronic enhancer regulates expression of the CFTR gene by direct interaction with the promoter.
  3. (2004). A gateway-compatible yeast one-hybrid system.
  4. (2000). A naturally occurring sequence variation that creates a YY1 element is associated with increased cystic fibrosis transmembrane conductance regulator gene expression.
  5. (1996). A regulatory element in intron 1 of the cystic fibrosis transmembrane conductance regulator gene.
  6. (2001). An element in intron 1 of the CFTR gene augments intestinal expression in vivo.
  7. (2007). An evaluation of 3C-based methods to capture DNA interactions.
  8. (2009). An insulator element 30 to the CFTR gene binds CTCF and reveals an active chromatin hub in primary cells.
  9. (1999). Analysis of a DNase I hypersensitive site located -20.9kb upstream of the CFTR gene.
  10. (1999). Analysis of DNase-I-hypersensitive sites at the 30 end of the cystic fibrosis transmembrane conductance regulator gene (CFTR).
  11. (2001). Aniridia-associated translocations, DNase hypersensitivity, sequence comparison and transgenic analysis redefine the functional domain of PAX6.
  12. (1995). Basal expression of the cystic fibrosis transmembrane conductance regulator gene is dependent on protein kinase A activity.
  13. (2002). Capturing chromosome conformation.
  14. (1995). Characterization of DNase I hypersensitive sites in the 120kb 50 to the CFTR gene.
  15. (1996). Characterization of the cAMP response element of the cystic fibrosis transmembrane conductance regulator gene promoter.
  16. (2006). Circular chromosome conformation capture (4C) uncovers extensive networks of epigenetically regulated intraand interchromosomal interactions.
  17. (2009). Comprehensive mapping of long-range interactions reveals folding principles of the human genome.
  18. (2006). CTCF binding at the H19 imprinting control region mediates maternally inherited higher-order chromatin conformation to restrict enhancer access to
  19. (2008). CTCF mediates insulator function at the CFTR locus.
  20. (2004). CTCF mediates long-range chromatin looping and local histone modification in the beta-globin locus.
  21. (2009). CTCF: master weaver of the genome.
  22. (2009). Disease-causing 7.4kb cis-Regulatory deletion disrupting conserved non-coding sequences and their interaction with the FOXL2 promotor: implications for mutation screening.
  23. (2007). Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome.
  24. (2002). DNA polymorphisms in potential regulatory elements of the CFTR gene alter transcription factor binding.
  25. (2007). Enhancer identification through comparative genomics.
  26. (2007). GC- and AT-rich chromatin domains differ in conformation and histone modification status and are differentially modulated by Rpd3p.
  27. (2008). Gene regulation in the third dimension.
  28. (2007). Gene splicing and mutagenesis by PCR-driven overlap extension.
  29. (2009). Genomic views of distant-acting enhancers.
  30. (2004). High-throughput localization of functional elements by quantitative chromatin profiling.
  31. (2009). Histone modifications at human enhancers reflect global cell-type-specific gene expression.
  32. (2004). HNF1alpha is involved in tissue-specific regulation of CFTR gene expression.
  33. (2007). Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project.
  34. (2009). Intronic enhancers coordinate epithelial-specific looping of the active CFTR locus.
  35. (2005). Long-range control of gene expression: emerging mechanisms and disruption in disease.
  36. (2002). Looping and Interaction between Hypersensitive Sites in the Active beta-globin Locus.
  37. (2001). Making contacts on a nucleic acid polymer.
  38. (2006). Mapping chromatin interactions by chromosome conformation capture (3C).
  39. (2008). Mapping in vivo chromatin interactions in yeast suggests an extended chromatin fiber with regional variation in compaction.
  40. (2007). Mapping networks of physical interactions between genomic elements using 5C technology.
  41. (2006). Nuclear organization of active and inactive chromatin domains uncovered by chromosome conformation capture-on-chip (4C).
  42. (1992). Regulation of CFTR expression and function during differentiation of intestinal epithelial cells.
  43. (2005). Remote control of gene transcription.
  44. (2003). Spatial organization of gene expression: the active chromatin hub.
  45. (2006). The 3 C’s of chromosome conformation capture: controls, controls, controls.
  46. (2006). The active FMR1 promoter is associated with a large domain of altered chromatin conformation with embedded local histone modifications.
  47. (2005). The CFTR gene and regulation of its expression.
  48. (1991). The cystic fibrosis gene has a ‘‘housekeeping’’-type promoter and is expressed at low levels in cells of epithelial origin.
  49. (2007). The landscape of histone modifications across 1% of the human genome in five human cell lines.
  50. (1995). Transcription of cystic fibrosis transmembrane conductance regulator requires a CCAAT-like element for both basal and cAMP-mediated regulation.
  51. (2006). Transcriptional regulatory elements in the human genome.
  52. (2009). Yeast silent mating type loci form heterochromatic clusters through silencer protein-dependent long-range interactions.